CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

CD137 Stimulation Enhances Cetuximab-Induced Natural Killer: Dendritic Cell Priming of Antitumor T-Cell Immunity in Patients with Head and Neck Cancer

Published:2016-08-05 Issue:3 Volume:23 Page:707-716
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Srivastava Raghvendra M.,Trivedi Sumita,Concha-Benavente Fernando,Gibson Sandra P.,Reeder Carly,Ferrone Soldano,Ferris Robert L.

Funder

National Institute of Health

University of Pittsburgh Cancer Institute

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural killer cells: a future star for immunotherapy of head and neck squamous cell carcinoma;Frontiers in Immunology;2024-08-21

2. NK cell based immunotherapy against oral squamous cell carcinoma;Frontiers in Immunology;2024-08-13

3. Final results of urelumab, an anti-CD137 agonist monoclonal antibody, in combination with cetuximab or nivolumab in patients with advanced solid tumors;Journal for ImmunoTherapy of Cancer;2024-03

4. Advances in tumor immune microenvironment of head and neck squamous cell carcinoma: A review of literature;Medicine;2024-03-01

5. The dynamic role of immune checkpoint molecules in diagnosis, prognosis, and treatment of head and neck cancers;Biomedicine & Pharmacotherapy;2024-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP